Class I homeobox (HOX) genes comprise a large family of transcription factors that have been implicated in normal and malignant hematopoiesis. However, data on their expression or function during T-cell development is limited. Using degenerated RT-PCR and Affymetrix microarray analysis, we analyzed the expression pattern of this gene family in human multipotent stem cells from fetal liver (FL) and adult bone marrow (ABM), and in T-cell progenitors from child thymus. We show that FL and ABM stem cells are similar in terms of HOX gene expression, but significant differences were observed between these two cell types and child thymocytes. As the most immature thymocytes are derived from immigrated FL and ABM stem cells, this indicates a drastic change in HOX gene expression upon entry into the thymus. Further analysis of HOX-A7, HOX-A9, HOX-A10, and HOX-A11 expression with specific RT-PCR in all thymocyte differentiation stages showed a sequential loss of 3 0 region HOX-A cluster genes during intrathymic T-cell development and an unexpected expression of HOX-A11, previously not recognized to play a role in hematopoiesis. Also HOX-B3 and HOX-C4 were expressed throughout thymocyte development. Overall, these data provide novel evidence for an important role of certain HOX genes in human T-cell development.
Introduction
Class I homeobox (HOX) genes code for transcription factors that are characterized by a highly conserved region of 60 amino acids that is responsible for DNA binding. 1 Generally, this gene family is divided into two different classes. Class I HOX genes were discovered in Drosophila because of the appearance of the so-called 'homeotic mutations', mutations that cause transformation of one part of the body into another. 2 In the genome of vertebrates, they are arranged in four different gene clusters and share a high degree of homology. In man, 39 HOX members have been identified so far. 3 Class II homeobox genes are the divergent homeobox genes. These genes have less homology.
Originally identified as master regulatory genes during embryogenesis, research over the last decade has provided ample evidence to postulate that the HOX gene family is also able to control proliferation and differentiation of hematopoietic cells. [4] [5] [6] Various reports have indicated the involvement of HOX genes in leukemogenesis, underlining their role in normal hematopoiesis. Several HOX genes are involved in the transformation of hematopoietic cells as a result of translocation events, especially with NUP98, a nucleoporin gene. [7] [8] [9] [10] Furthermore, high-level expression of both HOX-A9 and HOX-A10 is frequently detected in leukemic blasts from patients with acute myeloid leukemia, [11] [12] [13] and also HOX-B6 was recently implicated in this transformation proces. 14 The HOX-C locus has been primarily implicated in lymphomas. 15 Hematopoietic cells are derived from stem cells that reside in fetal liver (FL) in the embryo and in the adult bone marrow (ABM), which have the unique ability to self-renew and thereby provide a life-long supply of blood cells. T lymphocytes are a specific type of hematopoietic cells that play a major role in the immune system. They develop through a well-defined order of differentiation steps in the thymus. 16 Several transcription factors have a crucial role in this developmental process, [17] [18] [19] [20] [21] resulting in a complex regulatory network. 22 Little is known, however, if HOX genes also play a role during T-cell development. A crucial role for HOX-A9 in this developmental process was elucidated by the generation of HOX-A9 À/À mice. 23 Thymocytes from these animals are blocked at an early stage of differentiation. 24 Other evidence for the role of HOX genes in thymopoiesis came from a study in which enforced expression of HOX-B3 resulted in skewing of T-cell progenitors towards the gd T-cell lineage instead of the ab-lineage.
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Human CD34
+ lineage-marker negative (Lin À ) FL stem cells have been shown previously to generate T cells, 26 while in contrast, ABM stem cells seem to have a strongly diminished capacity to generate these cells. 27, 28 In this study, we therefore compared the expression pattern of HOX genes between highly purified CD34 + Lin À cells from both sources to investigate if differences in HOX gene expression are present that can account for the difference in T-cell differentiation potential. In addition, to have a better insight in which genes might be involved in T-cell development, we also analyzed HOX gene expression in the earliest multipotent progenitor cells in the human thymus and in the earliest T-cell committed progenitor cells. 29 We show that in terms of HOX gene expression, virtually no difference could be detected between FL and ABM stem cells, but that important differences in the expression pattern of this gene family were apparent between thymic and nonthymic precursor cells. Furthermore, specific RT-PCR reactions for selected genes showed an intriguing expression profile for HOX-A cluster genes during human thymocyte development and expression of HOX-B3 and HOX-C4 throughout this developmental pathway.
Materials and methods

Monoclonal antibodies
Mouse anti-human MoAbs used were CD1a (OKT6 fluorescein isothiocyanate (FITC)), CD3 (OKT3 FITC), CD4 (OKT4 FITC), CD7 (3A1 FITC), CD8a (OKT8 FITC) and CD19 (Leu12) from American Type Culture Collection (ATCC, Rockville, MD, USA); CD3 (Leu-4 phycoerythrin (PE) or allophycocyanine (APC)), CD4 (Leu-3a PE or APC), CD34 (HPCA-2 FITC, PE or APC) and CD69 (L78 PE) from Becton Dickinson Immunocytometry Systems (BDIS, Mountain View, CA, USA); CD1a (T6 PE) and TCR panab (BMA031 PE) from Coulter (Miami, FL, USA); glycophorin-A (10F7MN) and CD8b (2ST8.5H7 unlabeled or FITC), a kind gift of Dr L Lanier (DNAX, Palo Alto, CA, USA) and Dr E Reinherz (Dana-Farber Cancer Institute, Boston, MA, USA), respectively. Rat anti-mouse-IgG 2a+b (X57 PE) from BDIS was used to detect the unlabeled CD8b antibody.
Cell sources
FL tissues were obtained after legal termination of pregnancy, ABM was collected from healthy donors, and child thymus (CT) was obtained from children undergoing cardiac surgery. All human tissues were obtained with informed consent and used according to the guidelines of the Medical Ethical Commission of the University Hospital Ghent. FL cells were isolated by gentle disruption of the tissue in complete medium (Iscove's modified Dulbecco's medium/10% fetal calf serum (FCS), all from Invitrogen, Carlsbad, CA, USA). Child thymocytes were obtained by cutting the thymic tissue into small pieces of 0.5 cm Â 0.5 cm, which were then extensively teased apart with cataract knives in serum-free RPMI 1640 medium (Invitrogen). Mononuclear cells from all tissues were obtained by densitygradient centrifugation over Lymphoprep (Nyegaard, Oslo, Norway) and were subsequently resuspended in 9 vol FCS (Invitrogen) and 1 vol dimethyl sulfoxide (Serva, Heidelberg, Germany), and cryopreserved in liquid N 2 until use.
Purification of hematopoietic precursor cells and thymocyte subsets
After thawing and washing the cells, cells were labeled with lineage-specific antibodies and precursor cells from all human tissues were enriched by immunomagnetic depletion of Lin + cells (using sheep anti-mouse Ig-coated Dynabeads (Dynal AS, Oslo, Norway) with a ratio cells/Dynabeads of 1/5), followed by cell sorting. In case of FL and ABM, Lin + cells were immunodepleted with antibodies against glycophorin A, CD19 and CD7-FITC and remaining cells were subsequently labeled with CD34-PE and CD1-, CD3-, CD4-and CD8a-FITC to allow sorting of CD34 À cells, thymocytes were labeled with CD8a-FITC, TCRab-PE and CD4-APC. Cells were sorted on a FACS Vantage (BDIS) using CellQuest software (BDIS) and checked for purity, which was always at least 98.5%.
RNA isolation, RT-PCR, cloning of PCR products and sequence analysis
RNA from purified progenitor cells and different thymocyte subsets was isolated using Trizol (Invitrogen) according to the instructions of the supplier, treated with DNAseI (Promega Coorporation, Madison, WI, USA) to avoid genomic DNA contamination, and cDNA was prepared using Superscript (Invitrogen) following the guidelines of the manufacturer. HOX homeodomain degenerated primers used for amplification were modified at the 5 0 -end by providing restriction sites that were not present in any of the 39 homeodomains, to facilitate subsequent cloning into the pUC18 plasmid (Invitrogen). A BamHI site was included in the forward primer: 5 0 -GCGGATCCGA(AG)(TC)TI-GA(AG)AA(AG)GA(AG)TT(CT)C(AT)IT(AT)(CT)A-3 0 and a HindIII site in the reverse primer:
0 . Individual clones were analyzed by running cycle sequencing products (ABI PRISM BigDye Terminator cycle sequencing kit, Applied Biosystems, Foster City, CA, USA) on an ABI PRISM 310 Genetic Analyzer (Applied Biosystems) to identify the expressed homeobox genes. Specific primers for selected HOX genes are given in Table 1 . All reactions were performed using Taq Polymerase (Perkin-Elmer, Emeryville, CA, USA) with an initial denaturation step of 2 min at 941C, except for HOX-A9 PCR for which we used Taq Gold Polymerase (Perkin-Elmer) with an initial denaturation step of 12 min at 941C. Conditions were as follows: For hypoxanthine guanine phosphoribosyl transferase (HPRT) and HOX-A7: as described for HPRT 30 ; for HOX-A9: 40 cycles of 30 s at 941C, 40 s at 601C and 40 s at 721C; for HOX-A10: 35 cycles of 30 s at 941C, 30 s at 681C and 1 min at 721C; for Table 1 Specific primers used for RT-PCR (5 0 -3 0 ) HPRT  TATGGACAGGACTGAACGTCTTGC  GACACAAACATGATTCAAATCCCTGA  HOX-A7  AGCCCCCTTTATCAGAGC  TTCATCATCGTCCTCCTCG  HOX-A9  TCGATCCCAATAACCCAGC  CACTCGTCTTTTGCTCGG  HOX-A10  AGAGCAGCAAAGCCTCGCCG  AAGTTGGCTGTGAGCTCCCGGATCC  HOX-A11  CGTGCGCGAAGTGACCTTCAGAGAGTAC  CCTGCCCACGGTGCTATAGAAATTGGAC  HOX-B3  GGTTGCCAATGTCCGGTCCTGAG  GTGCGTGGCGGCCTGAAATG  HOX-C4 TATAGCTGCACCAGTCTCC GACCTGACTTTGGTGTTGG 
Gene of interest Forward primer Reverse primer
Microarray analysis
RNA was isolated using RNeasy columns as described by the manufacturer (Qiagen, Hilden, Germany). The integrity of the RNA was tested on 1% formaldehyde containing agarose gels. RNA (5 mg) was used to generate ds cDNA using superscript reverse transcriptase and a T7-oligo dT primer. The resulting cDNA was used in an in vitro cRNA reaction using T7 RNA polymerase and biotinylated ribonucleotides employing an ENZO kit (ENZO, Farmingdale, NY, USA). The biotinylated cRNA was cleaned up using RNeasy spin columns (Qiagen) and quantified by spectrophotometric methods. An adjusted cRNA yield was calculated to reflect carryover of unlabeled total RNA. Fragmentation of 20 mg cRNA was performed at 951C for 35 min. cRNA (10 mg) was subsequently hybridized for 16 h to a HG-U133A or a HG-U133B microarray (Affymetrix, Santa Clara, CA, USA) at 451C. After washing and staining, the arrays were scanned in an HP/Affymetrix scanner at 570 nm. For all experiments, the 5 0 /3 0 ratios of GAPDH were between 0.9 and 1.5.
The scanned images were analyzed using Affymetrix Microarray Suite 5.0 software, and the signal intensity of detected transcripts is shown.
Results and discussion
To identify HOX genes that have a potential role in T-cell development, we purified hematopoietic stem cells from different sources as well as T-cell progenitors from the thymus, and analyzed these populations for HOX gene expression. We, therefore, used RT-PCR with degenerated primers that recognize the most highly conserved region of the homeodomain, followed by cloning and sequence analysis. This approach has been previously shown to yield representative data. 31 In Table 2 , an overview is given of the total number of clones that was sequenced for each cell population and of the number of different HOX genes that were identified. The most remarkable overall feature was the high frequency of HOX-A cluster genes compared to HOX-B, HOX-C and HOX-D cluster genes. This seems to indicate that this is the most active HOX cluster during early human hematopoiesis. Especially HOX-A7, HOX-A9 and HOX-A10 were detected at high levels. The relative expression levels of all detected HOX genes within the various cell populations are shown in Figure 1 (Figure 1a for HOX-A and HOX-D cluster genes, Figure 1b for HOX-B and HOX-C cluster genes).
As the used method of PCR amplification of RNA with degenerate homeodomain primers might not be quantitative, we also performed microarray analysis on sorted CD1
À and CD1 + subpopulations of CD34 progenitor thymocytes. Figure 2 shows the results of two independent experiments. Although all the HOX genes are represented on the microarray chips, only transcripts for seven HOX genes were detected. Comparable to 
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the method of PCR amplification, the HOX-A cluster seemed to be over-represented, with HOX-A5, HOX-A7, HOX-A9, and HOX-A10 transcripts detected in both populations and in both experiments except for the HOX-A7 transcript in the CD1 + CD34 progenitor cells which was only detected once. In addition, HOX-C4 was detected once in the CD1 À CD34 progenitor cells, whereas HOX-C8 and HOX-D8 were detected once in the CD1 + CD34 progenitor cells. Whereas these data confirm that mainly HOX-A cluster genes are expressed in hematopoietic stem/progenitor cells, it is also clear that microarray analysis is less sensitive (although a sensitivity of 1:300 000 can be obtained) and does not detect low expressed HOX genes (which are apparently expressed below the threshold mentioned). Nevertheless, the microarray data provide quantitative confirmation of the high expression of HOX-A genes, as initially found by RT-PCR. Other reports confirm that mainly HOX-A cluster genes are expressed in hematopoietic stem cells; in one report the PCR amplification and sequencing approach was used, 31 in two more recent reports microarray analysis was used.
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Fetal liver and adult bone marrow progenitors show little difference in HOX gene expression profile 27,28 Therefore, we investigated if differences in HOX gene expression could account for this difference. However, virtually no differences were observed (Figure 1) . In both fractions, high levels of HOX-A7 and HOX-A9 were detected, which is in accordance with the data from Sauvageau et al. 31 However, in contrast to the same report, but in agreement with recent data, 33 we were also able to detect HOX-B4 expression with the degenerated primers, which correlates with the primitive differentiation stage of these cells. 34, 35 Indeed, FL and ABM CD34 + Lin À cells have been shown to be multipotential, reminiscent of a stem cell phenotype. 36, 37 It has been postulated that in hematopoiesis especially 3 0 region HOX genes (characterized by the numbers 1-6) are expressed in the most primitive cells, while at later stages of differentiation more 5 0 region HOX genes (7-13) become expressed, 31 in accordance with the colinear expression pattern that is observed during embryonic development. 3 In the case of FL CD34 + Lin À cells, 36% of the clones analyzed contained 3 0 region HOX genes, while in the case of the ABM cells with the same phenotype, this was 39%. Therefore, this indicates the presence of primitive progenitor cells in both populations. Surprisingly, the expression frequency of HOX-A1 and HOX-B1 was higher in ABM-derived progenitors (Figure 1 ). This was unexpected as generally FL cells are regarded as more primitive cells than ABM cells. One small difference between both cell fractions was the expression of HOX-B3, which was detected in ABM cells but not in FL progenitors (Figure 1b) . In terms of T-cell differentiation, it has been shown that enforced expression of this gene in mice bone marrow cells results in a reduced development of TCRab T cells. 25 As ABM CD34 + Lin À cells have a reduced capacity to generate these cells, 27, 28 one might correlate the expression of this gene in ABM progenitors with this feature. However, the detection rate of this gene was too low to give convincing evidence and suggests that only a minor fraction of the ABM cells expresses HOX-B3. Furthermore, a specific RT-PCR showed expression of this gene throughout all stages of TCR-ab T-cell development (Figure 3b) , indicating a role for this gene during development of this T-cell lineage as discussed further on.
HOX-A9 is expressed at a relative higher level in FL compared to ABM cells ( Figure 1a) and has previously been shown to be required for T-cell development, 24 but other data have implicated this gene in differentiation of other hematopoietic lineages as well 23 and possibly also in stem cell self-renewal. 33, 38 Therefore, it is impossible to associate the higher expression level of HOX-A9 in FL progenitors compared to ABM precursor cells with the increased ability of the former to generate T cells. Overall, however, the data show that there is no major difference between CD34 + Lin À precursor cells from FL and ABM in terms of HOX gene expression, and therefore it seems that this gene family is not responsible for the difference in T-cell differentiation potential .
HOX gene expression during human T-cell development
To have a better insight in which HOX genes might be involved in T-cell differentiation, we also analyzed the expression of this gene family in the earliest T-cell precursors within the human thymus, namely in CD34 + CD1 À cells, which are still multipotential, and in CD34 + CD1
+ cells, which are committed to the T-cell lineage. Larger differences in terms of HOX gene expression were observed when comparing FL and ABM populations with both CT populations ( Figure 1 ). As the former populations are the precursor cells that migrate towards the thymus to enable T-cell development, it seems that upon thymic entry a substantial change in HOX gene expression occurs. Overall, the expression of 3 0 region genes was reduced within these CT populations (17% in CD34 + CD1 À cells and 26% in CD34 + CD1 + cells) compared to FL (36%) and ABM (39%) CD34 + Lin À cells, suggesting that upon entry of progenitor cells within the thymus, differentiation is already occurring, even in the most immature CD34 + CD1 À CT cells. In accordance, HOX-B4, a gene that has been associated with stem cell selfrenewal, 34, 35 is virtually absent within both CT populations (Figure 1b) . This is in agreement with previous reports that discussed the absence of true stem cell characteristics within human CD34
+ thymocytes compared to similar cell fractions from other sources. 39 ,40 Surprisingly, the relative expression level of HOX-A9 is severely reduced upon thymic entry (CD34 + CD1 À cells), despite the fact that this gene is essential during T-cell development. 24 However, once the cells become T-cell committed (CD34 + CD1 + cells), HOX-A9 expression is upregulated again (Figure 1a) . Owing to the fact that in HOX-A9 À/À mice the block in T-cell development is after entry of precursor cells into the thymus, 24 this might indicate that HOX-A9 has no crucial role in the earliest multipotential progenitor cells in the thymus, but only becomes important once these cells are developing towards the T-cell lineage. To investigate this in more detail, we analyzed HOX-A9 expression in cell populations that represent the different stages of human T-cell development. This shows that only in the early stages of T-cell development HOX-A9 is expressed, compatible with its essential role during early differentiation (Figure 3b ). HOX-A9-deficient murine thymocytes display a reduced expression of the receptor for IL-7, 24 a necessary cytokine during the early phases of T-cell development. 41 As the expression profile of HOX-A9 (Figures 2 and 3b ) corresponds remarkably well with the IL-7-dependent stages of thymocyte differentiation (Figure 3a) , this suggests that also in human this gene is involved in the regulation of the IL-7 receptor. The lack of HOX-A9 expression at later stages of TCR-ab T-cell development (Figure 3b ) seems to indicate that this gene is dispensable for the final maturation of human T cells.
HOX-B3 was also detected within the CT populations, but at a low frequency (Figure 1b) . As HOX-B3 overexpression mainly results in TCR-gd T-cell development, 25 the expression of this gene in early T-cell development might reflect their potential to differentiate towards this lineage. However, upon further analysis, we observed that HOX-B3 is expressed at all stages of human TCR-ab T-cell development (Figure 3b ), suggesting that this gene is required for the development of this T-cell lineage as well. This might indicate that slight changes in HOX-B3 expression can be decisive for the TCR-ab-vs TCR-gd-lineage choice.
HOX-C4 expression has previously been detected in T-cell leukemias and in normal peripheral T cells 42 and it is shown here that also ABM and CT progenitor cells express this gene (Figure 1b) . We further investigated the expression of this gene during human thymopoiesis and it is shown that HOX-C4 is expressed at all stages of T-cell development (Figure 3b) . Combined with the expression in peripheral T cells, 42 this result suggests a potential role of this gene during normal development of T cells. Recently, the effect of HOX-C4 overexpression in human CD34
+ cells was analyzed, but no data on T-cell development were given. 43 The most obvious feature of CT precursor cells is the high expression level of HOX-A10 compared to FL and ABM CD34 + Lin À cells, especially within the CD34 + CD1 À CT fraction (63% of all clones analyzed, Figure 1a ). These data would therefore suggest a role for HOX-A10 in T-cell development. To further investigate this, we developed a specific RT-PCR that shows that HOX-A10 is expressed in immature thymocytes but is absent in single positive CD4 and CD8 mature thymocytes (Figure 3b ). This correlates with the observation that enforced expression of this gene in CD34 + Lin À cord blood cells severely inhibits final differentiation of human T cells. 4 The observed inhibitory effect of overexpression of HOX-A10, however, does not imply that this gene is not involved or required for the early stages of T-cell development.
We were also able to detect HOX-A11 within both CT populations (Figure 1a ). This gene was not detected in FL or ABM precursor cells and has not been reported previously to be expressed in cells of hematopoietic origin. Further analysis with specific RT-PCR showed that HOX-A11 was expressed at all major stages of T-cell development (Figure 2b ), indicating that this HOX gene might have an important role in this developmental pathway.
HOX-A7 was one of the few genes that was expressed at a comparable level in all analyzed stem cell and progenitor cell populations (Figure 1a) . A specific RT-PCR in all thymocyte differentiation stages showed that this gene was only expressed in the very early stages of T-cell development (Figure 2 and 3b) .
A remarkable observation concerning the expression profile of the analyzed HOX-A cluster genes (HOX-A7, HOX-A9, HOX-A10 and HOX-A11, Figure 3b) is the fact that all these genes are expressed during the early stages of T-cell development, but more importantly, that further maturation is accompanied by the sequential downregulation of the most 3 0 region gene of this cluster. HOX-A7 is expressed in developing thymocytes until the CD4 This also suggests that the human T-cell development by itself should be regarded as a separate developmental system, in which HOX genes play a similar well-organized role as during embryonic development. 44 In conclusion, we have shown that upon differentiation towards the T-cell lineage, hematopoietic progenitor cells undergo important changes in terms of HOX gene expression and provide evidence that these genes are involved in the complex regulatory network of transcription factors that control human T-cell development. Our results should incite further study into the role of HOX genes in both normal and leukemic hematopoiesis.
